Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Asparaginyl-tRNA synthetase 1 pseudogene 2 (NARS1P2) is a human pseudogene related to the asparaginyl-tRNA synthetase family but does not produce a functional protein[2]. Pseudogenes are DNA sequences similar to functional genes but are generally non-functional due to mutations or lack of regulatory elements, and they do not encode active proteins. While the parent gene, asparaginyl-tRNA synthetase, is an enzyme involved in attaching asparagine to its corresponding tRNA during protein synthesis[1][4][7], NARS1P2 itself does not participate in these or any known biological or disease roles.\nPseudogenes such as NARS1P2 may have regulatory roles in gene expression by acting as decoys for regulatory RNAs or competing for RNA-binding proteins, but there is no direct experimental evidence for NARS1P2 in these functions[5]. NARS1P2 is not considered a therapeutic target, marker, or a molecule with safety concerns. Its listing as a target is incorrect: it is not a protein-coding gene, enzyme, receptor, transporter, or any classical therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Asparaginyl-tRNA synthetase 1 pseudogene 2 (NARS1P2).